Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab

Background: Trastuzumab is a monoclonal antibody against HER2-positive breast cancer. Despite improving the natural history of the disease, there is a number of patients who are resistant to it, whereas all patients will eventually develop resistance and disease will progress. Inconsistent preclinic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Genomics Proteomics
Main Authors: CHRISTODOULOU, CHRISTOS, OIKONOMOPOULOS, GEORGIOS, KOLIOU, GEORGIA ANGELIKI, KOSTOPOULOS, IOANNIS, KOTOULA, VASSILIKI, BOBOS, MATTHEOS, PENTHEROUDAKIS, GEORGE, LAZARIDIS, GEORGE, SKONDRA, MARIA, CHRISAFI, SOFIA, KOUTRAS, ANGELOS, BAFALOUKOS, DIMITRIOS, RAZIS, EVANGELIA, PAPADOPOULOU, KYRIAKI, PAPAKOSTAS, PAVLOS, KALOFONOS, HARALAMBOS P, PECTASIDES, DIMITRIOS, SKARLOS, PANTELIS, KALOGERAS, KONSTANTINE T, FOUNTZILAS, GEORGE
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6299784/
https://ncbi.nlm.nih.gov/pubmed/30343280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20105
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados